Literature DB >> 16399578

Adoptive transfer of allogeneic antigen-specific T cells.

Stanley R Riddell1, Marie Bleakley, Tetsuya Nishida, Carolina Berger, Edus H Warren.   

Abstract

Animal models and human studies of allogeneic hematopoietic cell transplantation (HCT) demonstrate that immunologic nonidentity between donor and recipient is responsible for a graft versus leukemia (GVL) effect that contributes to complete tumor eradication. A variety of immune cells have been implicated in the GVL effect including NK cells, B cells, and CD4(+) and CD8(+) T cells that recognize minor histocompatibility (H) or leukemia-associated antigens. Here we discuss strategies for employing T cells specific for minor H antigens to augment the GVL effect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16399578     DOI: 10.1016/j.bbmt.2005.10.025

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  15 in total

Review 1.  Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation.

Authors:  Richard J O'Reilly; Tao Dao; Guenther Koehne; David Scheinberg; Ekaterina Doubrovina
Journal:  Semin Immunol       Date:  2010-05-26       Impact factor: 11.130

Review 2.  Adoptive T cell therapy of cancer.

Authors:  Malcolm K Brenner; Helen E Heslop
Journal:  Curr Opin Immunol       Date:  2010-02-17       Impact factor: 7.486

3.  To ablate or not to ablate? HSCs in the T cell driver's seat.

Authors:  Claudio Anasetti; James J Mulé
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

4.  CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy.

Authors:  Kazue Watanabe; Susumu Suzuki; Michi Kamei; Shingo Toji; Takakazu Kawase; Toshitada Takahashi; Kiyotaka Kuzushima; Yoshiki Akatsuka
Journal:  Int J Hematol       Date:  2008-08-05       Impact factor: 2.490

Review 5.  Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses.

Authors:  Xin Feng; Kwok Min Hui; Hashem M Younes; Anthony G Brickner
Journal:  Trends Immunol       Date:  2008-10-25       Impact factor: 16.687

6.  DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells.

Authors:  Kellie V Rosinski; Nobuharu Fujii; Jeffrey K Mito; Kevin K W Koo; Suzanne M Xuereb; Olga Sala-Torra; James S Gibbs; Jerald P Radich; Yoshiki Akatsuka; Benoît J Van den Eynde; Stanley R Riddell; Edus H Warren
Journal:  Blood       Date:  2008-02-25       Impact factor: 22.113

Review 7.  Adoptive cell transfer: a clinical path to effective cancer immunotherapy.

Authors:  Steven A Rosenberg; Nicholas P Restifo; James C Yang; Richard A Morgan; Mark E Dudley
Journal:  Nat Rev Cancer       Date:  2008-04       Impact factor: 60.716

Review 8.  Pathophysiology of acute graft-versus-host disease: recent advances.

Authors:  Yaping Sun; Isao Tawara; Tomomi Toubai; Pavan Reddy
Journal:  Transl Res       Date:  2007-07-03       Impact factor: 7.012

9.  In vivo imaging of T cell delivery to tumors after adoptive transfer therapy.

Authors:  Mikael J Pittet; Jan Grimm; Cedric R Berger; Takahiko Tamura; Gregory Wojtkiewicz; Matthias Nahrendorf; Pedro Romero; Filip K Swirski; Ralph Weissleder
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

10.  Two host factors regulate persistence of H7-specific T cells injected in tumor-bearing mice.

Authors:  Marie-Christine Meunier; Chantal Baron; Claude Perreault
Journal:  PLoS One       Date:  2009-01-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.